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Molecular Mechanisms of Polycystic Kidney DiseaseThis special issue entitled Molecular Mechanisms of Polycystic
Kidney Disease is comprised of a comprehensive set of reviews and
research articles encompassing the scope of developments and under-
standing of the basic mechanisms underlying the development of
autosomal polycystic kidney diseases that are providing insight into
potential therapeutic targeting. Rennert et al. provide a comprehensive
review of the genetics of ADPKD including an analysis of the roles of
mutations, gene variations, and micro-RNAs in phenotypic variability
and disease etiology. The theme ofmodiﬁer genes is further developed
by Xiaogang Liwith particular emphasis on epigenetic modiﬁcation of
the Pkd genes. The function of PKD-encoded Polycystin proteins as
components of receptor complexes that regulate diverse intracellular
signaling pathways by phosphorylation/de-phosphorylation is intro-
duced by Xiaohong Li and further developed by Boucher et al.
Mechanisms of development and modiﬁcation of basic cellular
architecture including apico-basal and planar cell polarity are
discussed by Wilson and Happe et al, respectively with emphasis on
the associated inﬂuences on cell receptors, transporters, intracellular
signaling, proliferation, and differentiation including lumen forma-
tion. The importance of the putative role of cilia in PKD with regard
to mechanosensation, calcium inﬂux, differentiation, polarity and
signaling is reviewed by Winyard and Jenkins and with regard to
proliferation, cell cycle and centrosomal structure/function by Lee
et al. The counterpart to proliferation, apoptosis and abnormalities in
ADPKD progression are reviewed by Goilav. The central roles played
by the intracellular second messengers calcium and cAMP in cystic
expansion by proliferation and secretion are discussed by Abdul-
Majeed and Nauli and Wallace, respectively while the importance of
epidermal growth factor mediated mechanisms in both proliferation
and ion transport is demonstrated by Zheleznova et al. Fluid transport
mechanisms in ADPKD are reviewed by Terryn et al. and focus on
important roles for chloride and water channels.
The mechanosensory role of polycystins at the cell–matrix
interface is reviewed by Drummond and the mechanisms and
outcomes of cell–matrix malfunction in ADPKD interstitial ﬁbrosis,
are discussed in depth by Norman. Potential therapeutic targets are
addressed bymany authors and emerging PKD therapies are reviewed
by Caplan. A novel approach may be afforded by the application of0925-4439/$ – see front matter © 2011 Published by Elsevier B.V.
doi:10.1016/j.bbadis.2011.08.004gene modiﬁed human renal papillary progenitor cells, the isolation
and characterization of which are described by Ward et al.
Overall, current knowledge suggests the PKD results from
disrupted mechanotransduction from key Polycystin-containing
multiprotein receptor signaling sites at the cilium, cell–matrix and
cell–cell adhesion sites. Coordinated integration of diverse down-
stream signaling pathways is a prerequisite of normal cell shape,
differentiation, polarity, cell division and renal tubule morphogenesis.
To fully understand the mechanisms underlying the development and
progression of PKD it will be necessary to examine the detailed
interactions between cystic gene and protein networks before and
after birth through to adulthood and the precise impact of disruption
of these genes and their modiﬁers in PKD. To date, emerging therapies
focus on proliferative, signaling and secretory targets to delay cystic
expansion while future approaches may include gene replacement.Pat Wilson is a Professor of Medicine at the University
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